Stocktwits on MSN
IBRX stock rises overnight: Jim Cramer backs ImmunityBio as a very good spec amid biotech takeover wave
The FDA expanded approval of Anktiva plus BCG to include papillary-only bladder tumors earlier this month. ・A separate study ...
ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...
SurvivorNet on MSN
ESMO: Adding two-drug combination before bladder cancer surgery helped people live longer in major trial
Results from a large study show that adding two drugs, durvalumab and enfortumab vedotin, before bladder cancer surgery ...
AstraZeneca has reported positive Phase III VOLGA results for perioperative Imfinzi (durvalumab) plus neoadjuvant enfortumab vedotin in patients with muscle-invasive bladder cance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results